CY1122140T1 - Μεθοδος παραγωγης φαρμακολογικως καθαρων κρυσταλλων - Google Patents

Μεθοδος παραγωγης φαρμακολογικως καθαρων κρυσταλλων

Info

Publication number
CY1122140T1
CY1122140T1 CY20191101048T CY191101048T CY1122140T1 CY 1122140 T1 CY1122140 T1 CY 1122140T1 CY 20191101048 T CY20191101048 T CY 20191101048T CY 191101048 T CY191101048 T CY 191101048T CY 1122140 T1 CY1122140 T1 CY 1122140T1
Authority
CY
Cyprus
Prior art keywords
production
pharmaceutically pure
pure crystals
crystals
crystalline substances
Prior art date
Application number
CY20191101048T
Other languages
English (en)
Inventor
Thomas Stiefel
Ortwin Kottwitz
Original Assignee
Biosyn Arzneimittel Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosyn Arzneimittel Gmbh filed Critical Biosyn Arzneimittel Gmbh
Publication of CY1122140T1 publication Critical patent/CY1122140T1/el

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/02—Crystallisation from solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/0018—Evaporation of components of the mixture to be separated
    • B01D9/0027—Evaporation of components of the mixture to be separated by means of conveying fluid, e.g. spray-crystallisation
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B19/00—Selenium; Tellurium; Compounds thereof
    • C01B19/008—Salts of oxyacids of selenium or tellurium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)

Abstract

Η παρούσα εφεύρεση σχετίζεται με τρόπους και μεθόδους παραγωγής κρυστάλλων ή κρυσταλλικών ουσιών. Ιδιαίτερα, κρύσταλλοι ή κρυσταλλικές ουσίες που είναι χρήσιμα ως φαρμακευτικά συστατικά μπορούν να παρασκευαστούν.
CY20191101048T 2010-06-24 2019-10-07 Μεθοδος παραγωγης φαρμακολογικως καθαρων κρυσταλλων CY1122140T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10006596A EP2399658A1 (en) 2010-06-24 2010-06-24 Method for producing pharmacologically pure crystals
EP11727925.7A EP2585182B1 (en) 2010-06-24 2011-06-22 Method of producing pharmacologically pure crystals
PCT/EP2011/003099 WO2011160840A1 (en) 2010-06-24 2011-06-22 Method of producing pharmacologically pure crystals

Publications (1)

Publication Number Publication Date
CY1122140T1 true CY1122140T1 (el) 2020-11-25

Family

ID=43127806

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20191101048T CY1122140T1 (el) 2010-06-24 2019-10-07 Μεθοδος παραγωγης φαρμακολογικως καθαρων κρυσταλλων

Country Status (17)

Country Link
US (1) US8636973B2 (el)
EP (2) EP2399658A1 (el)
KR (1) KR101463186B1 (el)
CA (1) CA2802764C (el)
CY (1) CY1122140T1 (el)
DK (1) DK2585182T3 (el)
ES (1) ES2745734T3 (el)
HR (1) HRP20192068T1 (el)
HU (1) HUE045737T2 (el)
IL (1) IL223483A (el)
LT (1) LT2585182T (el)
MY (1) MY153904A (el)
PL (1) PL2585182T3 (el)
PT (1) PT2585182T (el)
RS (1) RS59550B1 (el)
SI (1) SI2585182T1 (el)
WO (1) WO2011160840A1 (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105540968B (zh) * 2015-01-13 2017-10-13 广东海洋大学 海水淡化和制盐一体化装置
CN114009734A (zh) * 2021-10-21 2022-02-08 肇东星湖生物科技有限公司 基于溶剂喷雾震荡的反溶剂降温结晶生产imp+gmp的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB557914A (en) * 1942-05-07 1943-12-10 James Arthur Reavell Improvements in or relating to methods of obtaining crystals from industrial liquors
US4190622A (en) * 1978-05-04 1980-02-26 Standard Oil Company (Ohio) Process for prilling urea
US6680032B1 (en) * 1984-04-07 2004-01-20 Bayer Ag Process and apparatus for preparing granulates
US5490907A (en) * 1989-01-23 1996-02-13 Agglo Inc. Method for treating sludges
DE4240576C2 (de) * 1992-12-04 1996-04-18 Degussa Alkalicyanid-Granulate und Verfahren zu ihrer Herstellung
DE19959668A1 (de) * 1999-12-10 2001-06-13 Degussa Rieselfähige Nicotinsäureamid-haltige Formlinge und Verfahren zu deren Herstellung
DE10150326A1 (de) * 2001-10-15 2003-04-24 Degussa Verfahren zur Herstellung von Alkalialkoholat- und Erdalkalialkoholat-Granulaten
WO2003101578A1 (en) 2002-05-31 2003-12-11 Accentus Plc Production of crystalline materials by using high intensity ultrasound
JO2790B1 (en) * 2002-11-26 2014-03-15 أومنيا فيرتيليزر ليمتد Apparatuses for the production of nitrate granules
US8834929B2 (en) * 2006-07-21 2014-09-16 Bend Research, Inc. Drying of drug-containing particles
CN101104520A (zh) * 2007-06-29 2008-01-16 先导（清远）稀有金属化工有限公司 一种亚硒酸钠的生产工艺

Also Published As

Publication number Publication date
LT2585182T (lt) 2019-09-25
MY153904A (en) 2015-04-15
PT2585182T (pt) 2019-11-27
RS59550B1 (sr) 2019-12-31
CA2802764C (en) 2015-12-22
US20130149232A1 (en) 2013-06-13
EP2585182A1 (en) 2013-05-01
HRP20192068T1 (hr) 2020-02-21
KR20130048767A (ko) 2013-05-10
EP2399658A1 (en) 2011-12-28
US8636973B2 (en) 2014-01-28
WO2011160840A1 (en) 2011-12-29
SI2585182T1 (sl) 2019-10-30
PL2585182T3 (pl) 2020-03-31
KR101463186B1 (ko) 2014-11-18
ES2745734T3 (es) 2020-03-03
CA2802764A1 (en) 2011-12-29
IL223483A (en) 2017-10-31
EP2585182B1 (en) 2019-08-21
HUE045737T2 (hu) 2020-01-28
DK2585182T3 (da) 2019-11-18

Similar Documents

Publication Publication Date Title
CY1123958T1 (el) Μεθοδος παρασκευης παραγωγων και ενδιαμεσων καρβαμοϋλπυριδονης
CY1123689T1 (el) Κρυσταλλικη μορφη ελευθερης βασης λορλατινιβης
CY1119843T1 (el) Φαινυλοξικη l-ορνιθινη και μεθοδοι παρασκευης αυτης
CY1126141T1 (el) Κρυσταλλικη μορφη του υδριτη ελευθερης βασης λορλατινιμπης
ECSP14026138A (es) Uracilos sustituidos bicíclicamente y uso de los mismos
NZ704662A (en) Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid
UA110054C2 (uk) Розгалужені похідні 3-фенілпропіонової кислоти і їх застосування
SV2011004019A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
BRPI0818893B8 (pt) compostos de tropano, suas composições farmacêuticas, seus usos e método in vitro de inibição de hsp90 em uma célula
UA113774C2 (xx) Полімерні наночастинки, що складаються з фінастериду та міноксидилу, спосіб їх виготовлення, водна суспензія, що їх містить, фармацевтична композиція на їх основі та їх застосування
CY1120204T1 (el) Αμορφη στερεα διασπορα για χρηση σε θεραπεια καρκινου του εγκεφαλο
EA201691216A1 (ru) Композиции линаклотида с замедленным высвобождением
EP2320740A4 (en) PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR PRODUCING LOW IMPURITY CONCENTRATIONS THEREOF
EA201171435A1 (ru) Твердые фармацевтические композиции и способы их получения
CY1116984T1 (el) ΠΑΡΑΓΩΓΑ [1,2,3]ΤΡΙΑΖΟΛΟ[4,5-d]ΠΥΡΙΜΙΔΙΝΗΣ ΩΣ ΑΓΩΝΙΣΤΕΣ ΥΠΟΔΟΧΕΑ ΚΑΝΝΑΒΙΝΟΕΙΔΩΝ 2
EA201170356A1 (ru) Полиморфные и аморфные формы лакозамида и аморфные композиции
EP2985282A4 (en) Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives
CY1111954T1 (el) Παραγωγα τετραϋδροναφθαλινιου, μεθοδοι για την παραγωγη αυτων και η χρηση αυτων ως αντιφλεγμονωδη
EA201201109A1 (ru) Прасугрель в тонкоизмельченной кристаллической форме и фармацевтическая композиция, содержащая его
PH12016500525A1 (en) Substituted phenylalanine derivatives
ECSP11011483A (es) Piperidinas sustituidas
CY1123044T1 (el) Νεες ενωσεις
CY1122140T1 (el) Μεθοδος παραγωγης φαρμακολογικως καθαρων κρυσταλλων
EA201300647A1 (ru) Оптимизированный синтез чистых неполиморфных кристаллических жёлчных кислот с заданным размером частиц
EA201600394A1 (ru) Трициклические соединения пиперидина